Mycobacterium Tuberculosis Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509242865

Publication Date:

September 27, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Tuberculosis is an infectious disease caused by mycobacterium tuberculosis and mainly affects the lungs.
The global market for Mycobacterium Tuberculosis Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Mycobacterium Tuberculosis Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Mycobacterium Tuberculosis Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Mycobacterium Tuberculosis Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Mycobacterium Tuberculosis Testing include Thermo Fisher Scientific, Danaher, Mediven, Osang Healthcare, Hologic, Roche, Abbott, Novacyt and DAAN Gene, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mycobacterium Tuberculosis Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Mycobacterium Tuberculosis Testing by region & country, by Type, and by Application.
The Mycobacterium Tuberculosis Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mycobacterium Tuberculosis Testing.
Market Segmentation
By Company
Thermo Fisher Scientific
Danaher
Mediven
Osang Healthcare
Hologic
Roche
Abbott
Novacyt
DAAN Gene
Segment by Type:
Point of Care Test
Nuclear Acid Amplification Tests
Tuberculosis Skin Test
Others
Segment by Application
Hospitals
Specialty Clinics
Diagnostic Laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Mycobacterium Tuberculosis Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Mycobacterium Tuberculosis Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Mycobacterium Tuberculosis Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Mycobacterium Tuberculosis Testing Product Introduction
1.2 Global Mycobacterium Tuberculosis Testing Market Size Forecast
1.3 Mycobacterium Tuberculosis Testing Market Trends & Drivers
1.3.1 Mycobacterium Tuberculosis Testing Industry Trends
1.3.2 Mycobacterium Tuberculosis Testing Market Drivers & Opportunity
1.3.3 Mycobacterium Tuberculosis Testing Market Challenges
1.3.4 Mycobacterium Tuberculosis Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Mycobacterium Tuberculosis Testing Players Revenue Ranking (2023)
2.2 Global Mycobacterium Tuberculosis Testing Revenue by Company (2019-2024)
2.3 Key Companies Mycobacterium Tuberculosis Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Mycobacterium Tuberculosis Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Mycobacterium Tuberculosis Testing
2.6 Mycobacterium Tuberculosis Testing Market Competitive Analysis
2.6.1 Mycobacterium Tuberculosis Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Mycobacterium Tuberculosis Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycobacterium Tuberculosis Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Point of Care Test
3.1.2 Nuclear Acid Amplification Tests
3.1.3 Tuberculosis Skin Test
3.1.4 Others
3.2 Global Mycobacterium Tuberculosis Testing Sales Value by Type
3.2.1 Global Mycobacterium Tuberculosis Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Mycobacterium Tuberculosis Testing Sales Value, by Type (2019-2030)
3.2.3 Global Mycobacterium Tuberculosis Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Specialty Clinics
4.1.3 Diagnostic Laboratories
4.2 Global Mycobacterium Tuberculosis Testing Sales Value by Application
4.2.1 Global Mycobacterium Tuberculosis Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Mycobacterium Tuberculosis Testing Sales Value, by Application (2019-2030)
4.2.3 Global Mycobacterium Tuberculosis Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Mycobacterium Tuberculosis Testing Sales Value by Region
5.1.1 Global Mycobacterium Tuberculosis Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Mycobacterium Tuberculosis Testing Sales Value by Region (2019-2024)
5.1.3 Global Mycobacterium Tuberculosis Testing Sales Value by Region (2025-2030)
5.1.4 Global Mycobacterium Tuberculosis Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Mycobacterium Tuberculosis Testing Sales Value, 2019-2030
5.2.2 North America Mycobacterium Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Mycobacterium Tuberculosis Testing Sales Value, 2019-2030
5.3.2 Europe Mycobacterium Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Mycobacterium Tuberculosis Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Mycobacterium Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Mycobacterium Tuberculosis Testing Sales Value, 2019-2030
5.5.2 South America Mycobacterium Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Mycobacterium Tuberculosis Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Mycobacterium Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Mycobacterium Tuberculosis Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Mycobacterium Tuberculosis Testing Sales Value
6.3 United States
6.3.1 United States Mycobacterium Tuberculosis Testing Sales Value, 2019-2030
6.3.2 United States Mycobacterium Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Mycobacterium Tuberculosis Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Mycobacterium Tuberculosis Testing Sales Value, 2019-2030
6.4.2 Europe Mycobacterium Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Mycobacterium Tuberculosis Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Mycobacterium Tuberculosis Testing Sales Value, 2019-2030
6.5.2 China Mycobacterium Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Mycobacterium Tuberculosis Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Mycobacterium Tuberculosis Testing Sales Value, 2019-2030
6.6.2 Japan Mycobacterium Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Mycobacterium Tuberculosis Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Mycobacterium Tuberculosis Testing Sales Value, 2019-2030
6.7.2 South Korea Mycobacterium Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Mycobacterium Tuberculosis Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Mycobacterium Tuberculosis Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Mycobacterium Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Mycobacterium Tuberculosis Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Mycobacterium Tuberculosis Testing Sales Value, 2019-2030
6.9.2 India Mycobacterium Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Mycobacterium Tuberculosis Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific Mycobacterium Tuberculosis Testing Products, Services and Solutions
7.1.4 Thermo Fisher Scientific Mycobacterium Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Danaher
7.2.1 Danaher Profile
7.2.2 Danaher Main Business
7.2.3 Danaher Mycobacterium Tuberculosis Testing Products, Services and Solutions
7.2.4 Danaher Mycobacterium Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Danaher Recent Developments
7.3 Mediven
7.3.1 Mediven Profile
7.3.2 Mediven Main Business
7.3.3 Mediven Mycobacterium Tuberculosis Testing Products, Services and Solutions
7.3.4 Mediven Mycobacterium Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Osang Healthcare Recent Developments
7.4 Osang Healthcare
7.4.1 Osang Healthcare Profile
7.4.2 Osang Healthcare Main Business
7.4.3 Osang Healthcare Mycobacterium Tuberculosis Testing Products, Services and Solutions
7.4.4 Osang Healthcare Mycobacterium Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Osang Healthcare Recent Developments
7.5 Hologic
7.5.1 Hologic Profile
7.5.2 Hologic Main Business
7.5.3 Hologic Mycobacterium Tuberculosis Testing Products, Services and Solutions
7.5.4 Hologic Mycobacterium Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Hologic Recent Developments
7.6 Roche
7.6.1 Roche Profile
7.6.2 Roche Main Business
7.6.3 Roche Mycobacterium Tuberculosis Testing Products, Services and Solutions
7.6.4 Roche Mycobacterium Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Roche Recent Developments
7.7 Abbott
7.7.1 Abbott Profile
7.7.2 Abbott Main Business
7.7.3 Abbott Mycobacterium Tuberculosis Testing Products, Services and Solutions
7.7.4 Abbott Mycobacterium Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.7.5 Abbott Recent Developments
7.8 Novacyt
7.8.1 Novacyt Profile
7.8.2 Novacyt Main Business
7.8.3 Novacyt Mycobacterium Tuberculosis Testing Products, Services and Solutions
7.8.4 Novacyt Mycobacterium Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Novacyt Recent Developments
7.9 DAAN Gene
7.9.1 DAAN Gene Profile
7.9.2 DAAN Gene Main Business
7.9.3 DAAN Gene Mycobacterium Tuberculosis Testing Products, Services and Solutions
7.9.4 DAAN Gene Mycobacterium Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.9.5 DAAN Gene Recent Developments
8 Industry Chain Analysis
8.1 Mycobacterium Tuberculosis Testing Industrial Chain
8.2 Mycobacterium Tuberculosis Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Mycobacterium Tuberculosis Testing Sales Model
8.5.2 Sales Channel
8.5.3 Mycobacterium Tuberculosis Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Thermo Fisher Scientific
Danaher
Mediven
Osang Healthcare
Hologic
Roche
Abbott
Novacyt
DAAN Gene

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂